Articles
GRIN plasmonics
Gradient index (GRIN) plasmonics is a hybrid technology that opens the door to a wide range of exotic optics, including superfast computers based on light rather than electronic signals, ultra-powerful optical microscopes able to resolve DNA molecules with visible light, and ‘invisibility’ carpet-cloaking devices.
[ + ]IPTA and AusBiotech champion the Intellectual Property Laws Amendments
IPTA and AusBiotech are urging the Senate Legal and Consitutional Committee to favour the Intellectual Property Laws Amendments instead of patentable subject matter amendments, as they are more comprehensive in terms of Australian patent law.
[ + ]How blood stem cells regenerate themselves
Researchers at the Walter and Eliza Hall Institute have revealed the role of a key gene in enabling blood stem cells to renew themselves, a finding that might have implications for issue repair and transplantations. [ + ]
Simple tips for avoiding ‘information overload’
Today's scientists find they struggle to keep up with the information overload of our modern IT age. With a constant flow from multiple modes of communication, a plan to prioritise needs to be put in place.
[ + ]Feature: At the DNA vaccine vanguard
Ian Frazer and his team are pursuing an ambitious strategy to produce a DNA vaccine against herpes simplex virus 2. [ + ]
Feature: The challenge of a herpes simplex vaccine
Herpes simplex virus type 2 has managed to evade vaccine strategies to date, although DNA vaccines might finally offer a solution. [ + ]
Feature: Inside DNA vaccines
A radical new type of vaccine is on the horizon, one that uses the body’s own cellular machinery to provoke a comprehensive immune response. DNA vaccines offer many advantages over conventional vaccines. [ + ]
Feature: Lab managers must take can-do attitude
Lab managers need to avoid being too risk averse when working to accommodate researchers’ needs. [ + ]
Feature: To be a lab manager
Keeping a life science lab running smoothly and safely has become an increasingly complex and demanding task. [ + ]
Danaher to acquire Beckman Coulter for US$6.8 billion
US technology company, Danaher, is to acquire Beckman Coulter in a deal worth US$6.8 billion. [ + ]
Why astrobiology gives hope for cancer therapy
Astrobiologist Charles Lineweaver on the implications on cancer research of his recent paper suggesting cancer cells are like early multicellular life. [ + ]
Feature: Free radical
Dr Uta Wille bridges the gap between chemistry and biology and is bringing her unique insight to bear on the role played by free radicals in damaging DNA. [ + ]
Report card highlights Australia's research strengths and weaknesses
The Excellence in Research for Australia 2010 report shows that Australian researchers produce world class output in immunology, quantum physics and history, but fall behind in other areas. [ + ]
Feature: Developing a genetic therapy for Duchenne muscular dystrophy
Professor Steve Wilton presented the results of a recently completed clinical trial on a promising new genetic therapy for patients with muscular dystrophy at the AH&MR Congress. [ + ]